Webinars
This page contains exclusive content for the member of the following sections: TTS, TID. Log in to view.
Heart of the Matter
117.1 - Heart of the Matter: Infection and Xenotransplantation
Presenter: Kapil Saharia, Jay Fishman, Paige Porrett, , ,
Authors: Kapil Saharia, Jay Fishman, Paige Porrett, Stephanie Pouch, Wanessa Clemente
Learning Objectives
We will present the case of a patient with nonischemic cardiomyopathy who underwent heart transplantation from a genetically modified pig source animal and whose course was notable for detection of porcine CMV by plasma microbial cell-free DNA and xenograft failure.
Overview
- Describe infectious disease risk assessment and mitigation in potential xenograft donors
- Describe the selection of immunosuppressive regimens and prophylactic antimicrobials for human xenograft recipients
- Understand strategies to screen for and treat potential xenograft-related infections
Stephanie Pouch, USA
Moderator
Bio
Associate Director, Transplant Infectious Diseases
Emory University School of Medicine
Stephanie Pouch, MD, MS, FAST is an Associate Professor of Medicine and transplant infectious diseases physician at Emory University School of Medicine. Her clinical and research interests include multidrug-resistant bacterial infections in transplant recipients, as well as donor evaluation and donor-derived infections. She is active within the transplant community, serving as a Councilor in the TID Section of TTS, Co-Chair of the American Society of Transplantation Infectious Disease Community of Practice’s Donor Evaluation Working Group, and Vice Chair of the Organ Procurement and Transplantation Network Disease Transmission Advisory Committee.
Kapil Saharia, USA
Speaker
Bio
Institute of Human Virology Dept of Medicine,
Division of Infectious Diseases
University of Maryland School of Medicine
Kapil Saharia, MD, MPH is an Associate Professor of Medicine at University of Maryland School of Medicine and Section Chief of Solid Organ Transplant Infectious Diseases at University of Maryland Medical Center. He is the current Chair of the AST Infectious Diseases Community of Practice Safety/QI Working Group. His research interests include infectious disease outcomes research in solid organ transplant recipients and evaluation of novel diagnostic assays to improve the infectious disease management of solid organ transplant recipients.
Jay Fishman, USA
Speaker
Bio
Transplant Infectious Disease and Compromised Host Program
Associate Director Transplant Center
Massachusetts General Hospital
Jay A. Fishman, M.D. is Professor of Medicine at Harvard Medical School, Director of the Transplant Infectious Diseases and Compromised Host Program at the Massachusetts General Hospital (MGH), and Associate Director of the MGH Transplant Center. Dr. Fishman completed Internal Medicine and Infectious Disease training at MGH, and Fellowships in Molecular Biology and Genetics at Harvard Medical School. The Transplant Infectious Disease and Immunocompromised Host Program provides lifelong care for solid organ and stem cell transplant recipients and other immunocompromised hosts. With his background in immunology, virology and molecular biology, Dr. Fishman has defined the infectious risks in xenotransplantation, notably the role of porcine endogenous retrovirus and cytomegalovirus. He has over 300 peer-reviewed publications. He is Past-President of the American Society of Transplantation and Councilor of the International Xenotransplantation Association, Fellow of the American College of Physicians, American Society of Transplantation, and Infectious Disease Society of America.
Paige Porrett, USA
Speaker
Bio
University of Alabama at Birmingham
Dr. Porrett is the Director for Clinical & Translational Research or the UAB Comprehensive Transplant Institute. She is also the inaugural director for vascularized composite allotransplantation (VGA) for the UAB CTI . Dr. Porrett has diverse intellectual interests and expertise. Her NIH-funded immunology laboratory studies maternal immune cell fate and function during pregnancy in both human and animal models. Recently, Dr. Porrett expanded her portfolio to include xenotransplantation and has published the world's first experience of a clinical-grade, geneedited porcine kidney transplant into a human being.
Important Disclaimer
By viewing the material on this site you understand and accept that:
- The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
- The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
- The material is solely for educational purposes for qualified health care professionals.
- The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
- The information cannot be used as a substitute for professional care.
- The information does not represent a standard of care.
- No physician-patient relationship is being established.
Contact
Address
Transplant Infectious Disease
c/o The Transplantation Society
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada